Clinical Trials Directory

Trials / Unknown

UnknownNCT02423941

A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation

A Randomized Clinical Study of Retrograde Caval or Antegrade Portal Reperfusion for Early Graft Dysfunction Prevention in Deceased Brain Dead Donor Liver Transplantation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Republican Scientific and Practical Center for Organ and Tissue Transplantation · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Not accepted

Summary

To evaluate whether retrograde caval reperfusion of liver graft could be superior over antegrade portal reperfusion in regard of incidence and severity of early allograft liver dysfunction. All eligible enrolled liver transplant candidates will be randomized to receive either: 1. retrograde caval, followed by sequential portal-arterial, reperfusion or 2. antegrade, sequential portal-arterial reperfusion.

Detailed description

We hypothesize that retrograde caval reperfusion could be superior over antegrade portal reperfusion in regard of incidence and severity of early allograft liver dysfunction. Chi-square method of sample size estimation with a=0,05, b=0,20 and P1-P2 = 0,25 required a 41 subject per group (Stephen B Hulley, Steven R Cummings, Warren S Browner, Deborah G Grady, Thomas B Newman.-4th ed. Lippincott Williams \& Wilkins, 2013). After signing the informed consent 90 patients will be randomized to study and active-control group (45 each). Only patients undergoing classical technique (retrohepatic IVC resection) of liver transplantation without vena-venous bypass will be enrolled to the study. In the study group after completion of both caval anastomoses (super and infra-hepatic) the infra-hepatic cava-clamp is released and removed allowing the filling and flushing the liver retrogradely through the hepatic veins. 300 ml of blood is drained via donor portal vein and the vein will be clamped. Suprahepatic cava-clamp is released and removed allowing venous return to the right atrium. Portal vein anastomosis will be constructed. Before the last 2-3 stitches another 100 ml will be drained retrogradely. Recipient portal vein clamp is removed and liver will be reperfused antegradely. After that arterial and biliary anastomoses will be constructed. In the control group cava-clamps are not removed until completion the portal vein anastomosis. Chi-square test and regression analysis will be used to test the difference in incidence of early allograft liver dysfunction in the study groups. Mann-Whitney test will be used to compare the median of highest aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels 24 and 48 hours post-reperfusion.

Conditions

Interventions

TypeNameDescription
PROCEDURERetrogade reperfusionRetrogade caval reperfusion of the donor liver during the transplant procedure with consequent arterial reperfusion.
PROCEDUREAntegrade reperfusionAntegrade conventional portal reperfusion of the donor liver during the transplant procedure with consequent arterial reperfusion.

Timeline

Start date
2015-04-01
Primary completion
2017-01-01
Completion
2017-05-01
First posted
2015-04-22
Last updated
2017-01-04

Locations

1 site across 1 country: Belarus

Source: ClinicalTrials.gov record NCT02423941. Inclusion in this directory is not an endorsement.